NCT04033341View on ClinicalTrials.gov

A Study of LY3214996 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

September 9, 2019

Study Completion Date

September 9, 2019

Conditions
Healthy
Interventions
DRUG

LY3214996

Administered orally

DRUG

[14C]-LY3214996

Administered orally

Trial Locations (1)

53704

Covance Clinical Research Inc, Madison

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT04033341 - A Study of LY3214996 in Healthy Participants | Biotech Hunter | Biotech Hunter